Postoperative administration of ketorolac compared to other drugs for pain control after third molar surgery: A meta-analysis of double-blind, randomized, clinical trials
- PMID: 35083768
- DOI: 10.1111/bcp.15241
Postoperative administration of ketorolac compared to other drugs for pain control after third molar surgery: A meta-analysis of double-blind, randomized, clinical trials
Abstract
Aims: The aim of this study was to evaluate the analgesic effectiveness and adverse reactions of ketorolac in comparison with other drugs when administered postoperatively after third molar surgery.
Methods: PubMed and Google Scholar were utilized to search for articles comparing the efficacy and safety of ketorolac and other analgesic agents after third molar surgery. Data from papers with a lower risk of bias were recorded. The overall evaluation of analgesia onset, general and subgroup evaluation of the number of patients requiring rescue analgesic medication, general and subgroup assessment of the study medication (satisfaction on the study drugs), and the overall estimation of adverse effects were performed using the Review Manager Software 5.3 to analyse the data and obtain the meta-analysis plot.
Results: The subgroup evaluation of the study medication showed that patients who received ketorolac 30 mg were more satisfied than those who were given parecoxib 1 mg (odds ratio [OR] = 8.57, 95% confidence interval [CI] = 3.66-20.08, P = .00001), parecoxib 2 mg (OR = 7.17, 95% CI = 2.88-17.86, P = .0001), parecoxib 5 mg (OR = 3.03, 95% CI = 1.69-5.41, P = .0002), and parecoxib 10 mg (OR = 2.42, 95% CI = 1.36-4.32, P = .003). Moreover, patients who received ketorolac reported fewer adverse reactions compared with those who had received opioid analgesics (OR = 0.14, 95% CI = 0.32-1.76, P = .0001).
Conclusions: The data from this study demonstrates that the postoperative administration of ketorolac 30 mg presents better results on patient satisfaction when compared to parecoxib 1 mg to 10 mg, and presents a similar satisfaction to parecoxib 20 mg following third molar removal.
Keywords: diclofenac, opioid analgesics; ketorolac; parecoxib; third molar surgery.
© 2022 British Pharmacological Society.
References
REFERENCES
-
- Franco-de la Torre L, Figueroa-Fernández NP, Franco-González DL, Alonso-Castro ÁJ, Rivera-Luna F, Isiordia-Espinoza MA. A meta-analysis of the analgesic efficacy of single-doses of ibuprofen compared to traditional non-opioid analgesics following third molar surgery. Pharmaceuticals (Basel). 2021;14(4):360. doi:10.3390/ph14040360
-
- Isiordia-Espinoza MA, Franco-González MA, Alonso-Castro ÁJ, Franco-de la Torre L. Analgesic effectiveness and safety of celecoxib versus non-opioid active controls after third molar surgery: a meta-analytical evaluation. J Stomatol Oral Maxillofac Surg. 2021;S2468-7855(21)00141-5. doi:10.1016/j.jormas.2021.06.015
-
- Carrasco-Labra A, Brignardello-Petersen R, Yanine N, Araya I, Guyatt G Secondary versus primary closure techniques for the prevention of postoperative complications following removal of impacted mandibular third molars: a systematic review and meta-analysis of randomized controlled trials. J Oral Maxillofac Surg. 2012;70(8):e441-e457. doi:10.1016/j.joms.2012.03.017
-
- Al-Delayme RMA. Randomized clinical study comparing piezoelectric surgery with conventional rotatory osteotomy in mandibular third molars surgeries. Saudi Dent J. 2021;33(1):11-21. doi:10.1016/j.sdentj.2019.11.010
-
- Litvak KM, McEvoy GK. Ketorolac, an injectable nonnarcotic analgesic. Clin Pharm. 1990;9(12):921-935.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
